Edition:
United Kingdom

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

8.04USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$8.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
65,957
52-wk High
$23.68
52-wk Low
$5.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.67 -0.408
Mar '18 10.78 -0.363
FY 2017 Dec '17 11.28 -0.151
Sep '17 8.78 -0.285
Jun '17 0.00 -0.888
Mar '17 0.00 -0.841
FY 2016 Dec '16 0.00 -0.767
Sep '16 0.00 -0.503
Jun '16 0.00 -0.500
Mar '16 0.00 -0.804
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 15.21 27.80 7.82 --
Year Ending Dec-18 3 42.27 54.90 35.20 12.33
Year Ending Dec-19 3 24.77 43.80 12.50 28.27
Earnings (per share)
Quarter Ending Dec-18 3 -0.07 0.14 -0.20 -0.88
Year Ending Dec-18 3 -1.11 -0.73 -1.32 -2.70
Year Ending Dec-19 3 -1.82 -1.29 -2.20 -2.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.35 33.64
P/E High - Last 5 Yrs. -- 287.14 45.18
P/E Low - Last 5 Yrs. -- 89.68 23.74
Beta -- 0.93 0.88
Price to Sales (TTM) -- 124.53 5.83
Price to Book (MRQ) 5.19 15.28 4.89
Price to Tangible Book (MRQ) 5.20 14.51 6.51
Price to Cash Flow (TTM) -- 70.04 22.92
% Owned Institutions 88.75 14.28 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.41
Payout Ratio(TTM) -- 16.74 43.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.24 8.09
Sales (TTM) vs TTM 1 Yr. Ago -- 103.59 5.81
Sales - 5 Yr. Growth Rate -- 30.71 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -77.67 23.99 23.40
EPS (TTM) vs TTM 1 Yr. Ago -56.31 -- --
EPS - 5 Yr. Growth Rate -- 37.59 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.51 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 7.38 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.91 12.79
Total Debt to Equity (MRQ) 0.00 36.72 17.21
Interest Coverage (TTM) -5.03 -97.07 37.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.06 54.86
Gross Margin - 5 Yr. Avg. -- 48.98 52.38
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -578.76 11.01
Operating Margin (TTM) -- -789.30 4.03
Operating Margin - 5 Yr. Avg. -- -599.86 6.34
Pre-Tax Margin (TTM) -- -751.43 5.08
Pre-Tax Margin - 5 Yr. Avg. -- -605.48 6.78
Net Profit Margin (TTM) -- -752.40 1.35
Net Profit Margin - 5 Yr. Avg. -- -608.15 3.03
Effective Tax Rate (TTM) -- 23.50 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.68 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,659,931 807,592,034
Net Income/Employee (TTM) -1,354,629 1,701,937 94,981,854
Receivable Turnover (TTM) -- 20.75 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -99.82 -1.42 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -116.32 0.18 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -643.53 1.14 15.99
Return on Equity - 5 Yr. Avg. -- 2.73 16.87
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -152.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protagonist Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.27%
# of Holders: 88
Total Shares Held: 23,910,847
3 Mo. Net Change: 2,444,526
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.